New trial
Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
10 items · 0 changes to existing records
New trial
Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer Chemotherapy
Why it was picked newest record on or before this date
New paper
Current burden, incidence trends, and future projections of pancreatic cancer in adults worldwide.
Why it was picked newest record on or before this date
New trial
Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy
Why it was picked newest record on or before this date
New paper
Dual Targeting of FGFR4 and PI3K-mTOR Suppresses Tumor-Associated Phenotypes in Pancreatic Ductal Adenocarcinoma.
Why it was picked newest record on or before this date
Also today
New paper
Metabolic Dysfunction and Related Dietary Exposures in Relation to Pancreatic Cancer Risk: A Review of the Evidence.
New paper
Glycolysis and T cell-associated gene signature predicts prognosis and therapeutic responses in pancreatic cancer.
New paper
Compositional alterations in immune cells from obese mice impair anti-tumor cytotoxicity in pancreatic ductal adenocarcinoma.
New paper
Liquid Biopsy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.
Change tracking began 4 November 2026, after this day, so only its new records are listed.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.